NeuRA
Off the back of US approval of Leqembi, we have expert Dr Bill Brooks available to discuss Alzheimer’s disease.
Dr Brooks has studied Alzheimer’s Disease throughout his career and can comment on how the drug aims to work, what the evidence so far shows and also generally about Alzehimer’s disease and its progression.
/Public Release.
